losartan has been researched along with vasoactive intestinal peptide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baldi, E; Catalioto, RM; Cioni, A; Finetti, G; Maggi, M; Mancina, R; Renzetti, AR; Serio, M | 1 |
| Bennett, T; Gardiner, SM; Kemp, PA; March, JE; Rakhit, T | 1 |
2 other study(ies) available for losartan and vasoactive intestinal peptide
| Article | Year |
|---|---|
Identification and characterization of functional angiotensin II receptors in human neuroblastoma cells.
Topics: 1-Sarcosine-8-Isoleucine Angiotensin II; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Binding, Competitive; Biphenyl Compounds; Calcium; Cyclic AMP; Dose-Response Relationship, Drug; Humans; Imidazoles; Kinetics; Losartan; Neuroblastoma; Oligopeptides; Pyridines; Receptors, Angiotensin; Tetrazoles; Tumor Cells, Cultured; Vasoactive Intestinal Peptide | 1995 |
Regional haemodynamic responses to pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide in conscious rats.
Topics: Adrenergic beta-Antagonists; Angiotensin II; Animals; Arginine; Biphenyl Compounds; Dose-Response Relationship, Drug; Heart Rate; Hemodynamics; Imidazoles; Infusions, Intravenous; Losartan; Male; Neuropeptides; Neurotransmitter Agents; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pituitary Adenylate Cyclase-Activating Polypeptide; Propanolamines; Rats; Regional Blood Flow; Sodium Chloride; Tetrazoles; Vasoactive Intestinal Peptide | 1994 |